Počet záznamov: 1
kanagliflozín
SYS d000068896 LBL 00000nz--a2200181n--4500 005 20250606221740.8 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D02.886.778.075 065 $a D03.383.903.075 065 $a D09.408.348.113 066 $a 01 $c 03 150 $a kanagliflozín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a kanagliflozín hemihydrát $2 slo 550 $7 sllk_us_auth*d000077203 $Y Sodium-Glucose Transporter 2 Inhibitors $w P $a inhibítory SGLT2 665 $a 2016 (2014) $2 eng 680 9-
$i A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. $2 eng 750 -2
$a Canagliflozin $2 eng 980 $x M
Počet záznamov: 1